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700Objective: Most studies of anastomotic technique have been underpowered to detect subtle differences in sur-
vival. We analyzed the United Network for Organ Sharing database for trends in use and outcomes after either
bicaval or traditional (biatrial) anastomoses for heart implantation.
Methods: Review of United Network for Organ Sharing data identified 20,999 recipients of heart transplants
from 1997 to 2007. Patients were stratified based on the technique of atrial anastomosis: standard biatrial (atrial
group, n ¼ 11,919, 59.3%), bicaval (caval group, n ¼ 7661, 38.1%), or total orthotopic (total group, n ¼ 519,
2.6%).
Results: The use of the bicaval anastomosis is increasing, but many transplantations continue to use a biatrial
anastomosis (1997, 0.2% vs 97.6%; 2007, 62.0% vs 34.7%; P< .0001). Atrial group patients required perma-
nent pacemaker implantation more often (odds ratio, 2.6; 95% confidence interval, 2.2–3.1). Caval group patients
had a significant advantage in 30-day mortality (odds ratio, 0.83; 95% confidence interval, 0.75–0.93), and Cox
regression analysis confirmed the decreased long-term survival in the atrial group (hazard ratio, 1.11; 95% con-
fidence interval, 1.04–1.19).
Conclusions: Heart transplantations performed with bicaval anastomoses require postoperative permanent pace-
maker implantation at lower frequency and have a small but significant survival advantage compared with biatrial
anastomoses. We recommend that except where technical considerations require a biatrial technique, bicaval
anastomoses should be performed for heart transplantation. (J Thorac Cardiovasc Surg 2010;140:700-8)Supplemental material is available online.
After a fitful start in the late 1960s,1 cardiac transplantation
has become the treatment of choice for end-stage heart fail-
ure. Over the ensuing 40 years, significant advances have
been made in both the perioperative management of donors
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The Journal of Thoracic and Cardiovascular Surgtreat rejection; however, the most commonly performed
technique of cardiac allograft implantation, the standard,
or biatrial, technique, has remained little changed since its
initial description by Lower and Shumway in 1960.2
The primary advantage of the biatrial technique is its rel-
ative simplicity. By performing only 2 anastomoses to the
donor atria (rather than 6 to the 2 cavae and the 4 pulmonary
veins), the technical challenge of cardiac implantation is
lessened, and allograft ischemic times are reduced. How-
ever, the biatrial anastomosis puts the sinoatrial node at
risk of injury, and redundant atrial tissue might worsen atrial
hemodynamics and contribute to an increased risk of atrial
arrhythmias in the postoperative period.3,4
Attempts to solve these downsides resulted in the develop-
ment of 2 alternative techniques: bicaval and total heterotopic
cardiac transplantation.5-7 The bicaval anastomosis consists
of a single left atrial anastomosis with separate caval suture
lines, whereas total heterotopic transplantation divides the
left atrial anastomosis into 2 portions (left and right
pulmonary veins). These techniques are progressively more
complicated and might require longer operative times, but
they should result in a lower incidence of sinoatrial node
dysfunction and improved hemodynamic and physiologic
cardiac performance. Unfortunately, studies performed to
date to assess the results of these techniques have generally
been insufficiently powered (because of either small sampleery c September 2010
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CI ¼ confidence interval
PPM ¼ permanent pacemaker
UNOS ¼ United Network for Organ Sharing
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Xsizes8-14 or high frequency of missing data15) to detect impor-
tant differences.
This report uses data from the United Network for Organ
Sharing (UNOS) database to assess posttransplantation
outcomes in patients stratified by the technique used for al-
lograft implantation. Our goals were (1) to assess the current
use of these techniques and (2) to identify which techniques
resulted in better short- and long-term outcomes.
MATERIALS AND METHODS
Data Collection
UNOS provided deidentified patient-level, encrypted center–specific
data from the Thoracic Registry (data source no. 092707-15). The UNOS
Standard Transplant and Research Dataset contains information from the
UNOS forms, including the Transplant Candidate Registration form, the
Transplant Recipient Registration form, and the Transplant Recipient
Follow-up form. Use of these data is consistent with the regulations of
our university’s institutional review board.
Study Population
The study population consisted of 20,999 transplantations performed on
adult patients without congenital heart disease between 1997 and 2007 for
whom UNOS data included the type of anastomosis performed. Patients
were stratified based on the technique of atrial anastomosis: standard biatrial
(atrial group, n ¼ 11,919 [59.3%]), bicaval (caval group, n ¼ 7661
[38.1%]), or total orthotopic (total group, n ¼ 519 [2.6%])
Data Analysis
Statistical analysis was performed with SAS 9.13 software for Windows
(SAS Institute, Inc, Cary, NC). Primary outcomes were (1) the need for
a permanent pacemaker (PPM) before hospital discharge after transplanta-
tion and (2) 30-day mortality. Other outcomes included length of stay, the
incidence of in-hospital complications, long-term survival, graft survival,
transplant coronary artery disease–free survival, and renal failure–free
survival. Continuous variables are reported as means standard deviations
and were compared by using the Student’s t test.
Ordinal variables were compared by using the c2 test. Body surface area,
weight, and age were used as both continuous variables and stratified into
subgroups; the most predictive method was used. P values are all 2-sided.
Risk ratios and 95% confidence intervals (CIs) are also reported. Kaplan–
Meier analysis and Cox proportional hazards regression (PROC PHREG,
stepwise, P< .05) were used for time-to-event analysis. Survival function
estimates for strata of the explanatory variables were calculated with the
BASELINE statement of PROC PHREG. Multivariate regression (PROC
LOGISTIC, stepwise, P<.05) was also performed to evaluate the incidence
of peritransplantation death and the incidence of morbidity; all variables
reaching statistical significance in univariate analysis were included in mul-
tivariate analyses.
Missing Variables
Missing variables are a significant problem in analyses of large multi-
institutional databases in general and the UNOS database in particularThe Journal of Thoracic and Ca(see Table 1 for the proportion of missing data for each variable in our data-
set). For multivariate analyses, missing variables were imputed by using the
technique of multiple imputation, as implemented by using the MI and MI-
ANALYZE procedures (SAS 9.13 for Windows; see the Materials and
Methods section of this article’s Online Repository for full details of anal-
ysis). Multiple imputation has been shown to produce efficient and unbiased
estimates if the data are missing at random and even in the rarer situation of
information missing not at random.16-19 In circumstances with a high
proportion of missing variables, as is the case with the UNOS dataset (see
again), it provides more accurate estimates of true relationships than the
more commonly used method of listwise deletion. A full list of evaluated
variables is given in Table E2 in the Materials and Methods section of
this article’s Online Repository.
The authors had full access to the data and take full responsibility for its
integrity. All authors have read and agree with the manuscript as written.RESULTS
Anastomotic Technique
Baseline demographics and clinical status at the time of
transplantation in patients undergoing each anastomotic
technique are shown in Table 2. Since 1997, the use of
bicaval techniques has been steadily increasing, whereas
the number of total orthotopic transplantations has been de-
creasing (P ¼ .0001, Figure 1). However, 644 (34.5%)
transplantations in 2006 were still performed with a biatrial
anastomosis. The percentage of transplantations performed
with the bicaval technique was higher at higher-volume
transplant centers (P ¼ .0344, Figure 2).Short-Term Outcomes
Patients in the atrial group (n ¼ 576, 5.1%) required
a PPM before discharge more often (odds ratio [vs the caval
group], 2.6; 95% CI, 2.2–3.1) than those in the caval group
(n¼ 146, 2.0%) or the total group (n¼ 11, 1.9%; odds ratio
[vs the caval group], 1.0, 95% CI, 0.6–1.7). Multivariate
predictors of the need for PPM implantation included biatrial
anastomosis (odds ratio, 3.1; 95%CI, 2.5–3.9), donor age of
60 to 69 years (odds ratio, 2.9; 95% CI, 1.5–5.3), donor age
of 50 to 59 years (odds ratio, 2.0; 95% CI, 1.6–2.5), donor
age of 40 to 49 years (odds ratio, 1.3; 95% CI, 1.0–1.6), re-
cipient inotropic support at transplantation (odds ratio, 1.5;
95%CI, 1.2–1.7), donor history of hypertension (odds ratio,
1.2; 95% CI, 1.0–1.4), and transplantation year (odds ratio,
1.04; 95% CI 1.01–1.07 [per year]); use of T4 before organ
retrieval (odds ratio, 0.8; 95% CI, 0.6–0.9) was protective.
Length of stay was similar between patients requiring and
not requiring PPM implantation (21.8 vs 20.0 days,
P¼ .1360). Despite this, patients in the atrial group had lon-
ger posttransplantation lengths of-stay (21.1 days) than
those in the caval group (19.3 days, P< .0001).
In univariate analysis atrial group patients had a higher in-
cidence of postoperative death (8.9%; odds ratio, 1.17; 95%
CI, 1.05–1.30) than those in the caval group (7.6%; odds ra-
tio, 0.83; 95% CI, 0.75–0.93); postoperative mortality in the
total group (9.5%; odds ratio, 1.14; 95%CI, 0.86–1.53) was
not significantly different from that seen in either of the otherrdiovascular Surgery c Volume 140, Number 3 701
TABLE 1. Frequency of missing data for all variables included in
multivariate models predicting both long-term and short-term risk
of mortality (n ¼ 20,069)*
Risk factor Percentage missing
Albumin level at listing 43.5
Previous sternotomy 35.2
Panel reactive antibody level 35.0
Donor on T3 at organ retrieval 30.3
History of hepatitis B 12.0
Organ ischemic time 9.3
Transfusion between listing and transplantation 9.2
Bilirubin level at transplantation 7.8
Donor on T4 at organ retrieval 7.7
History of COPD 7.3
Creatinine clearance at transplantation 5.6
BMI at transplantation 5.6
Dialysis at transplantation 4.2
Recipient/donor weight ratio 3.6
History of stroke 3.0
History of hepatitis C 2.2
Donor bilirubin 2.2
History of diabetes 1.9
Donor history of hypertension 0.7
Donor cause of death 0.2
Donor age 0.1
Intravenous antibiotics within 2 wk 0.06
Hospital location (ICU vs non-ICU vs out of hospital) 0.01
Status at transplantation 0.01
Cause 0.0
Sex 0.0
Use of extracorporeal membrane oxygenation 0.0
Use of ventricular assist device 0.0
Use of intra-aortic balloon pump 0.0
Mechanical ventilation 0.0
Inhaled nitric oxide 0.0
Prostaglandin E 0.0
Donor ABO type 0.0
Donor cigarette use 0.0
Donor sex 0.0
Donor on inotropes/pressors 0.0
Recipient ABO type 0.0
Transplantation year 0.0
Anastomosis: total 0.0%y
Anastomosis: biatrial 0.0%y
COPD, Chronic obstructive pulmonary disease; BMI, bodymass index; ICU, intensive
care unit. *Variables with zero missing values are often variables calculated based on
responses where no option was given for ‘‘no,’’ and thus null results are assumed to be
‘‘no’’ responses, resulting in no missing values. yBecause type of anastomosis was the
focus of this analysis, missing values were not imputed for this variable, and 327 pa-
tients without anastomotic data were excluded.
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Xgroups. However, the logistic regression model predicting
postoperative death did not include type of anastomosis
(Table 3).Long-Term Outcomes
The long-term hazard of PPM implantation was also
significantly higher among patients in the atrial group702 The Journal of Thoracic and Cardiovascular Surg(P<.0001, Figure 3); at 2 years, 8.6% required a pacemaker
versus only 5.4% in the caval group and 4.0% in the total
group. Multivariate predictors of time to posttransplantation
PPM insertion included recipient age (odds ratio, 1.006;
95% CI, 1.001–1.012 [per year]), transfusions between list-
ing and transplantation (odds ratio, 1.2; 95% CI, 1.0–1.4),
donor age of 50 to 59 years (odds ratio, 1.6; 95% CI,
1.3–2.0), donor age of 60 to 69 years (odds ratio, 2.2;
95% CI, 1.3–3.7), transplantation year (odds ratio, 1.25;
95% CI, 1.21–1.28 [per year]), and biatrial anastomosis
(odds ratio, 2.5; 95% CI, 2.2–2.9); ventricular assist device
at transplantation was protective in this model (odds ratio,
0.7; 95% CI, 0.6–0.9).
There was a small but significant difference in long-term
survival between the atrial and caval groups in univariate
analysis (survival at 1 year, 85.6% vs 87.1%; at 5 years,
72.2% vs 73.5%; at 10 years, 51.1% vs 57.4%;
P<.0168; Figure 4). Multivariate Cox proportional hazards
regression analysis confirmed the decreased survival among
patients in the atrial group (hazard ratio, 1.11; 95% CI,
1.04–1.19; Table 4). There was no difference in graft
survival, renal failure–free survival, and transplant coronary
atherosclerosis–free survival based on anastomotic
technique.
DISCUSSION
Our results demonstrate a small but significant survival
advantage in multivariate analysis for patients undergoing
a bicaval anastomosis for cardiac allograft implantation.
Heretofore, the evidence in the literature has been somewhat
contradictory. Although some previous studies demon-
strated a survival advantage with the use of the bicaval
technique,20-22 which was confirmed in a meta-analysis by
Schnoor and colleagues,8 a recent analysis of the UNOS
dataset by Weiss and associates15 showed no difference
between groups.
The smaller studies20-22 (and by extension the meta-
analysis8) are all susceptible to bias because they used
only univariate analysis and failed to account for the corre-
lation between the use of the bicaval technique and in-
creased experience over time. However, an analysis of the
UNOS dataset from 1999 to 2005 by Weiss and associ-
ates15 did not show a similar advantage. We hope that
our results might clarify the reasons for this discrepancy
in the literature and confirm the advantages of the bicaval
technique.
Although we have analyzed a similar patient population,
our results appear to conflict with the recently published
analysis by Weiss and associates,15 also looking at the
UNOS dataset. The easy justification for the different results
obtained here would be the additional patients we were able
to include by using data through 2007; however, we specu-
late that more interesting and more important differences in
analytic techniques explain the differing results. Theseery c September 2010
TABLE 2. Pretransplantation demographic and clinical variables divided by type of transplant anastomosis
Atrial group Caval group Total group P value
Sex (male) 9054 (75.9%) 5815 (77.0%) 456 (76.0%) .23
Age (mean  95% CI) 52.2  0.3 51.9  0.3 51.9  1.1 .0001
Cause of heart failure
Dilated cardiomyopathy 9784 (82.1%) 6095 (80.7%) 502 (83.7%) .02
Congenital heart disease 241 (2.0%) 204 (2.7%) 19 (3.2%) .003
Ischemic cardiomyopathy 878 (7.4%) 556 (7.4%) 29 (4.8%) .06
Retransplantation 329 (2.8%) 241 (3.2%) 18 (3.0%) .22
Hypertrophic cardiomyopathy 173 (1.5%) 135 (1.8%) 5 (0.8%) .06
Restrictive cardiomyopathy 181 (1.5%) 127 (1.7%) 8 (1.3%) .60
ABO blood type
A 5146 (43.2%) 3240 (42.9%) 250 (41.7%) .74
B 1601 (13.4%) 1033 (13.7%) 81 (13.5%) .88
AB 604 (5.1%) 385 (5.1%) 31 (5.2%) .99
O 4568 (38.3%) 2892 (38.3%) 238 (39.7%) .80
Previous sternotomy 2981 (50.9%) 3129 (47.2%) 274 (53.1%) .0001
Days on waiting list (mean  95% CI) 241  8 196  10 158  25 .0001
Laboratory values at transplantation
Creatinine clearance<40 mL/min 536 (4.8%) 391 (5.4%) 31 (5.3%) .17
Total bilirubin>2.0 mg/dL 1207 (11.1%) 850 (12.0%) 69 (12.5%) .14
Albumin<3.5 mg/dL 1909 (34.6%) 1906 (35.7%) 169 (35.8%) .43
Medical history
Previous stroke 726 (6.3%) 411 (5.6%) 42 (7.1%) .05
Diabetes 2326 (20.0%) 1676 (22.4) 151 (25.4%) .0001
Chronic obstructive pulmonary disease 375 (3.4%) 229 (3.3%) 31 (5.5%) .02
Clinical status
Status 1/1 A/IB at transplantation 8683 (72.9%) 5710 (75.6%) 465 (77.5%) .0001
Inotropes 5744 (48.2%) 3663 (48.5%) 291 (48.5%) .90
Hospitalized (non-ICU) 2002 (16.8%) 1587 (21.0%) 124 (20.7%) .0001
ICU 4737 (39.8%) 2313 (30.6%) 240 (40.0%) .0001
Mechanical ventilation 370 (3.1%) 200 (2.7%) 19 (3.2%) .18
Ventricular assist device 2174 (18.2%) 1624 (21.5%) 118 (19.7%) .0001
Extracorporeal membrane oxygenation 39 (0.3%) 33 (0.4%) 1 (0.2%) .33
Transfusion between listing and transplantation 2129 (19.9%) 1484 (21.4%) 82 (14.3%) .0001
Antibiotics within 2 wk of transplantation 1208 (10.1%) 834 (11.1%) 78 (13.0%) .0189
Intra-aortic balloon pump 591 (5.0%) 434 (5.8%) 44 (7.3%) .0049
Transplantation year (mean) 2000 2003 2002 .0001
CI, Confidence interval; ICU, intensive care unit.
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Xdifferences, revolving around the handling of missing data,
merit detailed discussion because they influence any analy-
sis of the UNOS dataset.
A complete discussion of the statistical analysis of data-
sets containing missing data is well beyond the scope of
this article; however, because of its importance to this data
analysis, we will briefly address the advantages of multiple
imputation over other methods of dealing with missing
data, including listwise deletion (also known as complete
case analysis) and simple imputation. The appropriate han-
dling of missing data is essential to any analysis of the
UNOS dataset because it contains a significant amount of
missing data (see Table E1 and the Materials and Methods
section of this article’s Online Repository).
As with most analyses of large datasets (in part because it
is the default setting of statistical programs), Weiss and as-The Journal of Thoracic and Casociates15 have used complete case analysis, in which cases
missing variables included in the multivariate model are
eliminated from the analysis. This technique, although com-
mon,23 assumes that data are missing completely at random
(for a more complete discussion of the types of missing data,
see theMaterials andMethods section of this article’s Online
Repository); that is, it assumes that the group of patients with
complete data is identical to the entire group of interest (in
this case all adult patients undergoing transplantation).
This assumption is rarely borne out in analyses of missing
data in medical datasets, and despite its wide application,
the use of complete case analysis often leads to substantial
bias and poor predictive value.17
Simple imputation is another commonly used method to
account for missing values in large datasets. This involves
the replacement of all missing values for a particular variablerdiovascular Surgery c Volume 140, Number 3 703
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FIGURE 1. Transplantations performed by using each anastomosis type, as reported to the UNOS database by year from 1997 to 2007. White columns,
Number of biatrial anastomoses; black columns, number of bicaval anastomoses; cross-hatched columns, number of total orthotopic anastomosis. Lines in-
dicate the percentage of transplantations in that year performed with either biatrial (white diamonds) or bicaval (black diamonds) anastomosis. P< .0001.
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Xwith a particular result (often either the mean or mode over
the whole population). Although simple to implement and
easy to understand, it results in significant bias unless the
missing values are missing completely at random (ie, the
probability of a particular observation being missing is not
dependent on the value of that observation or any other
variable in the dataset).<10 10-25
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FIGURE 2. Scatter graph illustrating correlation between increasing transplant
anastomosis. Patients were divided into 4 groups based on total volume of transp
26–75 [up-pointing triangles], and>75 [down-pointing squares]). Each marker
plant center volume and on the y-axis by the percentage of transplantations perf
centage of bicaval transplantations performed in each volume group. P ¼ .034
bicaval transplantations.
704 The Journal of Thoracic and Cardiovascular SurgWe have chosen to use the technique of multiple imputa-
tion. Although this technique was developed to account for
data that were missing at random (ie, where the value of a par-
ticular variable does not influence the probability of it being
missing), it has been demonstrated to provide accurate ap-
proximations with appropriate 95% CIs, even where data is
missing not at random (see theMaterials andMethods section26-75 > 75
er Volume 2003-2007
ations and a larger percentage of transplantations performed with a bicaval
lantations performed from 2003 to 2007: (<10 [circles], 10–25 [diamonds],
represents a single transplant center and is plotted on the x-axis by the trans-
ormed by using bicaval anastomosis. Horizontal line indicates median per-
4 for correlation between increasing volume and increasing percentage of
ery c September 2010
TABLE 3. Multivariate logistic regression model of posttransplanta-
tion death (within 30 days or before discharge) among patients with
reported transplant anastomosis
Risk factor Odds ratio 95% CI
Extracorporeal membrane oxygenation 5.00 2.43–10.30
Cause: congenital heart disease 4.38 3.18–6.03
Prostaglandin E 3.67 1.41–9.52
Mechanical ventilation 2.85 2.24–3.63
Creatinine clearance<40 mL/min 2.26 1.85–2.78
Bilirubin>2.0 mg/dL 1.95 1.66–2.30
Ventricular assist device 1.87 1.60–2.19
Cause: retransplantation 1.85 1.36–2.52
Donor age 50–59 y 1.71 1.38–2.10
Ischemic time>4 h 1.64 1.42–1.89
Cause: restrictive cardiomyopathy 1.47 0.94–2.31
Cause: hypertrophic cardiomyopathy 1.46 0.89–2.38
Peak PRA>40% 1.38 1.10–1.74
Donor age 40–49 y 1.36 1.14–1.61
Donor age 30–39 y 1.25 1.06–1.47
Intravenous antibiotics within 2 wk 1.19 1.00–1.42
Donor cause of death: stroke 1.17 1.01–1.35
Cause: ischemic cardiomyopathy 1.14 0.92–1.42
Cause: valvular cardiomyopathy 1.06 0.73–1.54
Age (risk per additional year) 1.022 1.016–1.028
Transplantation year 0.93 0.92–0.95
Sex (male) 0.82 0.7–0.94
PRA, Panel reactive antibody.
Davies et al Cardiothoracic Transplantationof this article’s Online Repository for more information).24,25
In addition, by including patients with some missing
information, a much larger sample size can be used in the
multivariate analysis, permitting the identification of less1 2
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FIGURE 3. Kaplan–Meier estimates of the cumulative hazard of permanent pac
a function of the type of transplant anastomosis: CAVAL, Bicaval anastomosis; A
sis. Numbers of subjects at risk at each time point are given across the bottom, an
The Journal of Thoracic and Capowerful but still significant predictors of outcomes. Thus
multiple imputation allows more accurate inferences about
the entire population of interest (rather than only the
population with complete data), enabling both more precise
and more powerful data analysis. Details of our method of
multiple imputation are given in the Materials and Methods
section of this article’s Online Repository.
To return specifically to the analysis of transplant anasto-
mosis provided in this article, we were able to identify
biatrial anastomosis as having a hazard ratio for mortality
in Cox proportional hazards regression of 1.11 (95% CI,
1.04–1.19). This is in fact similar to the odds ratio shown
by Weiss and associates (1.06),15 except that their CIs
were wider and did not reach statistical significance. Even
in their analysis, it was similar in magnitude (if not in statis-
tical significance) to the hazard ratio for prolonged ischemic
time.15 Therefore although they concluded that ‘‘there was
no difference in survival between the bicaval and biatrial
technique,’’ we believe, and our analysis here supports,
that this was a matter of insufficient power because of the
exclusion of patients with missing data rather than the lack
of effect.
Unfortunately, because of the limitations of the UNOS
dataset, we can only speculate as to the cause of this differ-
ence in long-term mortality. Although previous studies have
not been sufficiently powered to demonstrate differences in
long-term mortality based on the anastomotic technique
during transplantation by using multivariate techniques, sev-
eral studies have demonstrated benefits to atrial physiology
in the posttransplantation period. These include improved
atrial emptying and decreased atrial diameter4,26 and4 6 8
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Xdecreased atrioventricular valve regurgitation (especially the
tricuspid valve).11 In some studies these have resulted in de-
monstrable improvements in cardiac output and pulmonary
vascular resistance 12 months after transplantation.11
The effect of differences in the need for posttransplanta-
tion PPM implantation on mortality is not clear. Consistent
with previous studies, we have demonstrated a significantly
higher rate of PPM implantation before discharge in patients
with a biatrial anastomosis, with an odds ratio of 3.1 in
multivariate analysis.8,10,27,28 Rothman and coworkers29
demonstrated increased levels of sinus node dysfunction
(attributed to surgical damage) in patients with biatrial anas-
tomoses. Our data, which show a persistently increased need
for pacemaker implantation over long-term follow-up,
suggest that ongoing interference with conductance path-
ways or nodal function occurs, possibly because of healing,
scar formation, and ongoing inflammation in the region of
the anastomosis. Other than implant technique, the most im-
portant predictors of the need for PPM insertion were related
to donor factors, especially increasing donor age and donor
history of hypertension, suggesting the importance of
subclinical donor cardiac disease on subtle aspects of post-
transplantation cardiac function.
Whether long-term electrical dysfunction and pacemaker
use explain the increased mortality or whether the increased
mortality with biatrial anastomosis can be explained by the
alterations in atrial hemodynamics shown by others8
remains unclear, and the UNOS dataset simply does not
contain the information required to address the causal rela-
tionship between transplant anastomosis and long-term mor-
tality. Similar limitations prevent an accurate assessment of706 The Journal of Thoracic and Cardiovascular Surgthe potential causative factors in the higher mortality evident
within the total orthotopic heart transplantation group. It is
possible that technical factors result in a higher incidence
of pulmonary venous stenosis or left atrial dysfunction in
these patients. Given the relative rarity of the use of this tech-
nique, the poor outcomes might also reflect poor outcomes
among a specific subset of surgeons, centers, or patients,
but without additional data, we can only speculate.
Interestingly, and in contrast to many previously pub-
lished models of posttransplantation mortality (although
not Weiss and associates15), our multivariate model does
not include year of transplantation as a predictor of long-
term mortality. We speculate on 2 possible causes for this
discrepancy. First, by limiting the analysis to the most recent
10 years, we might have excluded a significant amount of the
improvement in transplantation outcomes. More intrigu-
ingly, it is possible that the increasing prevalence of bicaval
anastomoses might be a causative factor in the decreasing
mortality after transplantation in more recent years.
Transplant center volume was only minimally correlated
with the percentage of procedures performed by using the
bicaval anastomosis. Center volume and anastomosis tech-
nique might also be confounded because high-volume
centers are more likely to perform complex reoperative
transplantations, particularly in patients with congenital
heart disease, in whom bicaval anastomosis might not be
possible. Critiques of studies examining the relationship be-
tween hospital volume and surgical outcomes often focus on
the fact that simply reporting volume–outcomes relation-
ships is less instructive than identifying the causal factors
underlying the relationship. We speculate that a portion ofery c September 2010
TABLE 4. Cox proportional hazards model of long-term survival
after transplantation
Risk factor Hazard ratio 95% CI
Extracorporeal membrane oxygenation 2.60 1.69–3.98
Prostaglandin E 1.83 1.06–3.18
Mechanical ventilation 1.75 1.50–2.03
Donor age 60–69 y 1.69 1.29–2.21
Cause: congenital heart disease 1.57 1.29–1.92
Creatinine clearance<40 mL/min 1.57 1.40–1.77
Donor age 50–59 y 1.53 1.39–1.77
Bilirubin>2.0 mg/dL 1.36 1.24–1.49
Anastomosis: total 1.31* 1.11–1.56
Cause: retransplantation 1.29 1.10–1.53
Donor age 40–49 y 1.29 1.19–1.40
Recipient: history of diabetes 1.29 1.20–1.38
Recipient: history of chronic
obstructive pulmonary disease
1.28 1.10–1.48
Ischemic time>4 h 1.21 1.12–1.31
Ventricular assist device 1.19 1.10–1.30
Donor age 30–39 y 1.19 1.09–1.29
Intravenous antibiotics within 2 wk 1.16 1.06–1.28
Recipient: history of previous stroke 1.16 1.03–1.30
Cause: restrictive cardiomyopathy 1.14 0.90–1.45
Anastomosis: biatrial 1.11* 1.04–1.19
Age (risk per additional year) 1.004 1.001–1.007
Cause: ischemic cardiomyopathy 0.97 0.87–1.08
Cause: valvular cardiomyopathy 0.95 0.7–1.14
Cause: hypertrophic cardiomyopathy 0.92 0.69–1.22
Donor–recipient sex match 0.92 0.86–0.98
Sex (male) 0.91 0.85–0.98
*Compared with the bicaval group.
Davies et al Cardiothoracic Transplantationthe improved outcomes at high-volume centers might be due
to their use of the bicaval technique.
Examination of surgeon rather than center volume might
be instructive in attempting to identify barriers to adoption of
the bicaval technique, but these data are not available in
UNOS. The duration of cardiopulmonary bypass and
warm organ ischemia might also be instructive because the
additional anastomosis has been criticized as taking longer.
However, in our experience we believe the bicaval technique
can be performed as quickly as, if not more quickly than, the
biatrial technique. Even if concerns regarding operative time
were accurate, our data clearly demonstrate a long-term sur-
vival advantage to the bicaval anastomosis.T
XLimitations
As described above, the UNOS dataset contains several
limitations that hinder our analysis. Although we have
used an established technique to deal with missing data,
missing information still limits the power of our analysis.
In particular, reoperative sternotomy is poorly entered,
despite the possibility that it is an important factor in early
posttransplantation mortality. More importantly in the con-
text of this analysis of surgical techniques, no data in theThe Journal of Thoracic and CaUNOS dataset address long-term atrial hemodynamic func-
tion or electrophysiology, which might better elucidate
causal relationships between the type of anastomosis and
long-term outcomes.CONCLUSIONS
Despite these limitations, we can conclude that in a multi-
variate analysis controlling for a large number of other risk
factors, the use of a bicaval anastomosis is associated with
improved long-term survival and freedom from PPM
implantation. In addition, short-term benefits, including a de-
creased length of stay (likely related to reductions in the need
for PPM before discharge), have also been clearly demon-
strated. Accordingly, we recommend the use of the bicaval
anastomosis for cardiac transplantation, except where ana-
tomic challenges preclude its use.
We thank UNOS for supplying these data and Katarina Ander-
son for her assistance with our analysis.References
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MATERIALS AND METHODS
This section details both the importance of the methods used to handle miss-
ing data in analysis of the UNOS dataset and the specific methods used in our
analysis. The UNOS database contains significant amounts of missing data
(Table E1).
An Overview of the Problem of Missing Data
What follows is a brief discussion of the statistical challenges raised by the
presence of missing values in research datasets. For additional information,
a range of publications with varying levels of statistical complexity is availa-
ble.E1-E7 Various methods of handling missing data have been described.
Commonly used methods include complete case analysis (or listwise
deletion), available case analysis, and overall mean imputation.E3 Although
these have the advantage of being relatively simple to implement and easy to
understand, they often result in a reduction in sample size and resultant loss
of power; more importantly, they also commonly lead to severely biased esti-
mates of statistical associations.E2,E3
Imputation is simply the replacement of missing values by using esti-
mates of those values. Mean imputation is a commonly used method in
which the mean of the nonmissing values is substituted for the missing
values. Unfortunately, this method assumes that the missing observations
are missing completely at random (ie, the probability of a particular obser-
vation being missing is unrelated to the value of the missing observation or
any other variable in the dataset). This method will result in severely biased
estimates when this unlikely assumption is not met and might result in bi-
ased estimates, even when the assumption is met.E3
A better method of imputing the missing values is to estimate them based
on a multivariate analysis of the known variables. These estimates are then
substituted for the missing variables in subsequent analyses. The drawback
of this method is that subsequent analyses are performed as if those
substituted values were observed rather than simply estimated, which results
in overestimation of the precision of the associations (ie, underestimation of
standard errors, P values, and 95% confidence intervals).E2,E3
Multiple imputation attempts to solve the problem of overestimation of
precision by creating multiple datasets, each with imputations drawn ran-
domly from the estimated distribution of the missing values. Each of the
multiple datasets is then analyzed, and statistical associations are estimated
along withmeasures of precision. The estimates are then averaged across the
datasets, and the measures of precision are combined. The result is an esti-
mate of the statistical association and an estimate of the precision of that as-
sociation that accurately reflect the error introduced by substituting
estimated values for missing values.E1,E3
Importance of Missing Data in the UNOS Dataset
Although Weiss and associatesE8 did not describe specific statistical anal-
ysis techniques or report the frequency of missing data, an analysis of the
UNOS database from 1995 to 2005 suggests that of the 16,962 patients un-
dergoing transplantations over that time period, only 10,799 (63.7%) had
complete information in the variables included in their multivariate model
and were therefore eligible for inclusion in the model. This much smaller
sample size might explain the lack of statistical power; in addition, given
the likelihood of introducing bias into statistical analyses by using complete
case analysis (particularly where the percentage of missing data is high),E3
the results of an analysis in which more than 35% of samples must be ex-
cluded should be viewed with skepticism. Multiple imputation has been
used by other authors to develop accurate statistical estimates from the
UNOS dataset despite the rate of missing data.E9-E11
Handling of Missing Data in This Study
Missing variables were imputed by using the MI procedure of SAS 9.13
for Windows. Because of limitations of computing power, not all variables
could be included in the imputation step; variables included are listed in
Table E2. The MI procedure uses a Markov chain Monte Carlo method in
which the missing values are replaced bym (m¼ 10 in this study) simulated
versions. Because simulation studies suggest that it provides the best esti-
mates in situations in which the proportion of missing values exceeds
30%, full-data imputation (IMPUTE ¼ FULL) was used.E4 The maximum
likelihood estimates for the means and covariance matrix of a multivariate
normal distribution of the dataset with missing values was computed by us-
ing the expectation–maximization algorithm with 400 maximal iterations.
Odds/hazard ratios and 95% confidence intervals were estimated by using
the MIANALYZE procedure.
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TABLE E1. Frequency of missing data for all variables included in
multivariate models predicting both long-term and short-term risk
of mortality (n ¼ 20,069)*
Risk factor
Percentage
missing
Albumin level at listing 43.5
Previous sternotomy 35.2
Panel reactive antibody level 35.0
Donor on T3 at organ retrieval 30.3
History of hepatitis B 12.0
Organ ischemic time 9.3
Transfusion between listing and transplantation 9.2
Bilirubin level at transplantation 7.8
Donor on T4 at organ retrieval 7.7
History of COPD 7.3
Creatinine clearance at transplantation 5.6
BMI at transplantation 5.6
Dialysis at transplantation 4.2
Recipient/donor weight ratio 3.6
History of stroke 3.0
History of hepatitis C 2.2
Donor bilirubin 2.2
History of diabetes 1.9
Donor history of hypertension 0.7
Donor cause of death 0.2
Donor age 0.1
Intravenous antibiotics within 2 wk 0.06
Hospital location (ICU vs non-ICU vs out of hospital) 0.01
Status at transplantation 0.01
Cause 0.0
Sex 0.0
Use of extracorporeal membrane oxygenation 0.0
Use of ventricular assist device 0.0
Use of intra-aortic balloon pump 0.0
Mechanical ventilation 0.0
Inhaled nitric oxide 0.0
Prostaglandin E 0.0
Donor ABO type 0.0
Donor cigarette use 0.0
Donor sex 0.0
Donor on inotropes/pressors 0.0
Recipient ABO type 0.0
Transplantation year 0.0
Anastomosis: total 0.0y
Anastomosis: biatrial 0.0y
COPD, Chronic obstructive pulmonary disease; BMI, bodymass index; ICU, intensive
care unit. *Variables with zero missing values are often variables calculated based on
responses in which no option was given for ‘‘no,’’ and thus null results are assumed to
be ‘‘no’’ responses, resulting in no missing values. yBecause anastomosis type was the
focus of this analysis, missing values were not imputed for this variable, and 327 pa-
tients without anastomosis data were excluded.
TABLE E2. List of variables included in the multiple imputation
procedure for imputation of missing variables
Albumin Location (ICU, non-ICU,
out of hospital)
Body mass index Mechanical ventilation
Body surface area Peak PRA level
CMV status Previous sternotomy
Creatinine Recipient bilirubin
Distance between recovery and
transplant centers
Recipient dialysis
Donor age Status at transplantation
Donor bilirubin Transplantation year
Hepatitis B Use of T3
Hepatitis C Use of T4
Ischemic time Ventricular assist device
ICU, Intensive care unit; PRA, panel reactive antibody; CMV, cytomegalovirus.
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